Posaconazole Injection
Product Images NDC 55150-388

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Posaconazole (NDC 55150-388). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Package Label-principal Display Panel-300 mg Per 16.7 mL (18 mg/ml)- Container Label (Posaconazole Fig1)

Package Label-principal Display Panel-300 mg Per 16.7 mL (18 mg/ml)- Container Label (Posaconazole Fig1)
This text appears to be the description of a medication called Posaconazole, which is available in a vial containing 300 mg of the active ingredient. The medication is manufactured in India for Eugia USLLC, and it is indicated for intravenous use. The usual dosage is not provided in the text and it is recommended to consult the prescribing information for that information. The vial needs to be diluted before infusion and should be stored refrigerated at 2° to 5°C. The diluted solution is a clear and colorless liquid, with variations of yellow color not affecting the quality of the product. Any unused portion of the medication should be discarded.*
FDA Label Image

Package Label-principal Display Panel-300 mg Per 16.7 mL (18 mg/ml) – Container-carton Label (Posaconazole Fig2)

Package Label-principal Display Panel-300 mg Per 16.7 mL (18 mg/ml) – Container-carton Label (Posaconazole Fig2)
FDA Label Image

Chemical-structure (Posaconazole Str)

Chemical-structure (Posaconazole Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.